Why the study?
Does short-term dual antiplatelet therapy (≤6 months) reduce or prevent myocardial infarction or stent thrombosis in patients after percutaneous coronary intervention for acute coronary syndrome compared to long-term DAPT?
Does short-term dual antiplatelet therapy (≤6 months) reduce or prevent myocardial infarction or stent thrombosis in patients after percutaneous coronary intervention for acute coronary syndrome compared to long-term DAPT?
Short-term DAPT (≤6 months) after PCI for ACS appears safe and does not increase the risk of ischemic events such as myocardial infarction or stent thrombosis compared to long-term DAPT.
Answers are grounded in this paper and cite their sources.
Supports shorter DAPT post-ACS PCI to limit bleeding without ischemic excess; reinforces meta-analytic safety data on duration.
Our meta-analysis demonstrated that short-term DAPT (<6 months) after PCI for ACS was not associated with increased risk of myocardial infarction or stent thrombosis when compared to long-term DAPT.
No takes yet. Share an insight, caveat, or question.
Misumida et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: